Inventor · disambiguated record
Johannes Bartholomaeus
Also filed as: BARTHOLOMAEUS JOHANNES · BARTHOLOMAEUS JOHANNES H A · BARTHOLOMAEUS JOHANNES HEINRIC
26 granted patents·31 pending applications·752 citations·filing 1996–2020
97Inventor score
Files withGRUENENTHAL GMBH42BARTHOLOMAEUS JOHANNES3GRUENENTHAL CHEMIE3ARKENAU ELISABETH1ARKENAU-MARIC ELISABETH1
Top patents by PatentIndex Score
57 records- 0198US9629807B2Abuse-proofed dosage formGRUENENTHAL GMBH·Filed 2016·Granted Apr 25, 2017·21 cites·29 claims
- 0297US9675610B2Abuse-proofed dosage formGRUENENTHAL GMBH·Filed 2016·Granted Jun 13, 2017·17 cites·20 claims
- 0397US5601842ASustained release drug formulation containing a tramadol saltGRUENENTHAL GMBH·Filed 1996·Granted Feb 11, 1997·234 cites·9 claims
- 0495US6685964B1Opioid analgesics with controlled active substance releaseGRUENENTHAL GMBH·Filed 2000·Granted Feb 3, 2004·112 cites·23 claims
- 0594US6576260B2Sustained-release form of administration containing tramadol saccharinateGRUENENTHAL GMBH·Filed 2002·Granted Jun 10, 2003·53 cites·62 claims
- 0694US6558701B2Multilayer tablet for administering a fixed combination of tramadol and diclofenacGRUENENTHAL GMBH·Filed 2001·Granted May 6, 2003·59 cites·45 claims
- 0793US8722086B2Dosage form with impeded abuseARKENAU-MARIĆ ELISABETH·Filed 2008·Granted May 13, 2014·42 cites·25 claims
- 0892US10369109B2Abuse-proofed dosage formGRUENENTHAL GMBH·Filed 2018·Granted Aug 6, 2019·5 cites·28 claims
- 0990US10058548B2Abuse-proofed dosage formGRUENENTHAL GMBH·Filed 2017·Granted Aug 28, 2018·4 cites·29 claims
- 1090US6558704B1Process for preparing pellets containing up to 90 wt.% of a pharmaceutical active ingredientGRUENENTHAL GMBH·Filed 2000·Granted May 6, 2003·41 cites·11 claims
- 1188US7906141B2Sustained-release, oral pharmaceutical forms of formulationGRUENENTHAL GMBH·Filed 2002·Granted Mar 15, 2011·28 cites·2 claims
- 1287US6451350B1Controlled release tramadol preparation with a storage-stable release profile and process for their productionGRUENENTHAL GMBH·Filed 2000·Granted Sep 17, 2002·25 cites·26 claims
- 1382US7897173B2Sustained-release, oral pharmaceutical formulations and methods of making and using sameGRUENENTHAL GMBH·Filed 2004·Granted Mar 1, 2011·14 cites·22 claims
- 1480US7994382B2Application system for a plaster containing an active ingredient and a controlled-release agent for said active ingredientGRUENENTHAL GMBH·Filed 2006·Granted Aug 9, 2011·1 cites·18 claims
- 1579US11007156B2Prolonged release pharmaceutical composition containing 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenolGRUENENTHAL GMBH·Filed 2019·Granted May 18, 2021·0 cites·26 claims
- 1678US7572463B2Oral dosage formsGRUENENTHAL GMBH·Filed 2002·Granted Aug 11, 2009·9 cites·65 claims
- 1776US2020375905A1Abuse-proofed dosage formGRUENENTHAL GMBH·Filed 2020·Application pending·0 cites
- 1875US2020215053A1Abuse-proofed dosage formGRUENENTHAL GMBH·Filed 2020·Application pending·0 cites
- 1974US2019321358A1Abuse-proofed dosage formGRUENENTHAL GMBH·Filed 2019·Application pending·0 cites
- 2073US6291462B1Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts or hydratesGRUENENTHAL GMBH·Filed 1999·Granted Sep 18, 2001·35 cites·13 claims
- 2173US2019282506A1Abuse-proofed dosage formGRUENENTHAL GMBH·Filed 2019·Application pending·0 cites
- 2272US5776492ARapidly disintegrating medicinal form of tramadol or a tramadol saltGRUENENTHAL GMBH·Filed 1996·Granted Jul 7, 1998·39 cites·6 claims
- 2371US7666860B2Melt-formulated, multi-particulate oral dosage formGRUENENTHAL GMBH·Filed 2006·Granted Feb 23, 2010·1 cites·35 claims
- 2471US2014170079A1Abuse-proofed dosage formGRUENENTHAL GMBH·Filed 2013·Application pending·0 cites
- 2571US2019008849A1Abuse-proofed dosage formGRUENENTHAL GMBH·Filed 2018·Application pending·0 cites
- 2670US8088322B2Method and device for ultrasound-pressing a tablet or a multiparticulate medicamentARKENAU-MARIC ELISABETH·Filed 2006·Granted Jan 3, 2012·2 cites·18 claims
- 2769US8133510B2Form of administration based on crosslinked hydrophilic polymersBARTHOLOMAEUS JOHANNES·Filed 2004·Granted Mar 13, 2012·4 cites·12 claims
- 2869US7410965B2Delayed release pharmaceutical composition containing 1-dimethyl-amino-3-(3-methoxyphenyl)-2-methyl-pentan-3-olGRUENENTHAL GMBH·Filed 2004·Granted Aug 12, 2008·1 cites·33 claims
- 2969US2015056147A1Abuse-proofed dosage formGRUENENTHAL GMBH·Filed 2014·Application pending·0 cites
- 3067US7669781B2Drinking straw comprising a reinforced sectionGRUENENTHAL GMBH·Filed 2007·Granted Mar 2, 2010·3 cites·6 claims
- 3167US2017239185A1Abuse-proofed dosage formGRUENENTHAL GMBH·Filed 2017·Application pending·0 cites
- 3267US2014093559A1Abuse-proofed dosage formGRUENENTHAL CHEMIE·Filed 2013·Application pending·0 cites
- 3366US2018221308A1Prolonged release pharmaceutical composition containing 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenolGRUENENTHAL GMBH·Filed 2018·Application pending·0 cites
- 3465US2016022587A1Abuse-proofed dosage formGRUENENTHAL GMBH·Filed 2015·Application pending·0 cites
- 3563US2008317854A1Process for the production of an abuse-proofed solid dosage formGRUENENTHAL CHEMIE·Filed 2008·Application pending·0 cites
- 3662US2013237608A1Prolonged Release Pharmaceutical Composition Containing 3-(3-Dimethylamino-1-Ethyl-2-Methyl-Propyl)PhenolGRUENENTHAL GMBH·Filed 2013·Application pending·0 cites
- 3762US2017087103A1Prolonged release pharmaceutical composition containing 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenolGRUENENTHAL GMBH·Filed 2016·Application pending·0 cites
- 3860US9839737B2Tubing set having a gate for the connection of vialsREITER REINHOLD·Filed 2010·Granted Dec 12, 2017·2 cites·17 claims
- 3960US2016151309A1Prolonged release pharmaceutical composition containing 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenolGRUENENTHAL GMBH·Filed 2016·Application pending·0 cites
- 4059US2005058706A1Delayed release pharmaceutical composition containing 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenolGRUENENTHAL CHEMIE·Filed 2004·Application pending·0 cites
- 4158US2012034304A1Prolonged Release Pharmaceutical Composition Containing 3-(3-Dimethylamino-1-Ethyl-2-Methyl-Propyl)PhenolBARTHOLOMAEUS JOHANNES·Filed 2011·Application pending·0 cites
- 4256US2007065365A1Abuse-resistant transdermal systemGRUENENTHAL GMBH·Filed 2006·Application pending·0 cites
- 4354US2005236741A1Process for the production of an abuse-proofed solid dosage formARKENAU ELISABETH·Filed 2004·Application pending·0 cites
- 4453US8173164B2Oral administration forms for administering a fixed tramadol and diclofenac combinationBARTHOLOMAEUS JOHANNES·Filed 2003·Granted May 8, 2012·0 cites·25 claims
- 4553US2010196473A1Pharmaceutical Composition Containing 6-dimethylaminomethyl-1-(3-methoxyphenyl)-cyclohexane-1,3-diol with Delayed Active Ingredient ReleaseGRUENENTHAL GMBH·Filed 2010·Application pending·0 cites
- 4652US2006121113A1Pharmaceutical composition containing 6-dimethylaminomethyl-1-(3-methoxyphenyl)-cyclohexane-1,3-diol with delayed active ingredient releaseGRUENENTHAL GMBH·Filed 2006·Application pending·0 cites
- 4751US2007053965A1Kit comprising a plaster, optionally containing an active substance, and an agent that at least partially reduces skin irritationGRUENENTHAL GMBH·Filed 2006·Application pending·0 cites
- 4851US2005191340A1Opioid-receptor antagonists in transdermal systems having buprenorphineGRUENENTHAL GMBH·Filed 2005·Application pending·0 cites
- 4949US9974805B2Phosphate binder formulation for simple dosingFRESENIUS MEDICAL CARE DEUTSCHLAND GMBH·Filed 2016·Granted May 22, 2018·0 cites·8 claims
- 5048US2003104061A1Controlled release tramadol preparations with a storage-stable release profile and process for their productionGRUENENTHAL GMBH·Filed 2002·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →